| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | XMD11-85h | GDSC1000 | pan-cancer | AAC | -0.005 | 0.9 |
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | -0.0039 | 0.9 |
| mRNA | GDC-0449 | FIMM | pan-cancer | AAC | 0.017 | 0.9 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0035 | 0.9 |
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | 0.0071 | 0.9 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | 0.0025 | 0.9 |
| mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | 0.0033 | 0.9 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | -0.0037 | 0.9 |
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | 0.003 | 0.9 |